Knowledge • News • Insights

In Partnership With

AP Lazer: Leading the Way

Flint & Genesee Group | Inside Business: McLaren Flint Announces $46 Million Expansion of Cancer Center

FlintGenesee-LogoFinal-GROUP-RGB

and region’s only proton therapy center

TO GROW COMPREHENSIVE ONCOLOGY CARE IN GENESEE COUNTY

A $46 million project is launching to expand the Karmanos Cancer Institute at McLaren Flint and the McLaren Proton Therapy Center. Once complete, the projects will allow more patients access to proton therapy, the most advanced radiation therapy available, and bring a more comprehensive approach to cancer care for Genesee County residents and beyond. The expansion is part of McLaren Flint’s continued commitment to grow comprehensive cancer care and ensure a multidisciplinary approach to individualize each cancer patient’s treatment.

“We are committed to serving the community by offering world-class cancer care right here in Genesee County,” said Chris Candela, president, and CEO of McLaren Flint. “Being part of the Karmanos Cancer Network gives cancer patients improved access to new treatments close to home. This expansion allows us to provide more treatment options, grow our team of respected oncologists with trailblazing specialties, and provide care for more patients, saving them daily travel throughout the county or to Detroit for treatment.”The project will include a 13,800-square-foot-vertical expansion of the cancer center, a 7,200-square-foot expansion of the proton therapy center, development of a third proton therapy vault with two patient treatment spaces, and parking lot and entry improvements. Groundbreaking is scheduled for the summer of 2022 with the first patient in the expanded cancer center expected in late 2023.

The $46 million expansion adds an oncology experience that has not been delivered in Genesee County. Recently, the Singh & Arora Oncology/Hematology practice joined the Karmanos Cancer Institute at McLaren Flint, further integrating medical oncology and hematology care at the cancer center. This brings all three cancer treatment modalities under one roof, including surgical oncology and radiation oncology (along with proton therapy), and gives patients more streamlined care.

Though all three modalities are housed at the cancer center, there are some Karmanos and McLaren oncology specialists who do not have space in the current cancer center. A patient treatment plan could require them to see a specialist in all three treatment modalities, which also include gynecologic oncologistshead and neck cancer specialists, surgical oncologists, and proton therapy specialists. With the expansion, there will now be more space for specialists to be housed in the same building, saving patients trips to multiple locations for treatment. Under this new plan for growth, multidisciplinary teams will have a more on-site collaborative approach to each patients’ treatment plan. This will enable the highest level of coordination of care for some of the most complex treatments.

In addition to expanding the cancer center, the McLaren Proton Therapy Center will begin the final phase of construction, which now includes a third vault with two patient treatment spaces. McLaren previously added a second room to meet the high demand for proton therapy. This final phase will allow the proton center to nearly double the capacity for treatment.

“We wanted to take our time and understand the demand for proton therapy in the area before we decided what the final phase would include,” said Hesham Gayar, MD, medical director of the McLaren Proton Therapy Center. “With growing interest and patients seeking treatment from all corners of the state, increasing our capacity will allow us to serve more patients and decrease the wait period to begin proton therapy treatments. We are proud to be able to give more people access to proton therapy right here in Flint.”

The McLaren Proton Therapy Center is one of only two in Michigan, offering advances in technology for the most precise tumor targeting available today. The McLaren Proton Therapy Center is one of the only centers in the world utilizing advanced synchrotron technology, which delivers the highest energies and the lowest risk of side effects from unnecessary radiation to the patient. The center’s advanced technology includes pencil-beam scanning and volumetric image-guided proton therapy, designed to treat tumors with extreme precision.

McLaren has retained Kramer Management Group as its owner’s representative. Barton Malow has been selected as the construction manager and Gresham Smith Partners is the architect for the project.

For more information on the cancer treatments available and the oncologists at Karmanos Cancer Institute at McLaren Flint and the McLaren Proton Therapy Center, visit karmanos.org/flintcancer.

About Flint & Genesee Group
Flint & Genesee Group supports the region through its commitment to developing business, talent, and place. Marketing its services through four divisions – Explore Flint & GeneseeFlint & Genesee Chamber, Flint & Genesee Economic Allianceand Flint & Genesee Education & Talent – as well as with community partners, the organization works to strengthen the Flint and Genesee County economy and create a place where people thrive, and businesses invest and grow. For more information, visit flintandgenesee.org, and check us out on FacebookLinkedIn and Twitter. 

What's Hot

Get the latest news from MBN right in your inbox

Sign up for our newsletter and never miss a beat.